Cite
Neurostimulation for cognitive enhancement in Alzheimer's disease (the NICE-AD study): a randomized clinical trial
MLA
Jessica Zwerling, et al. “Neurostimulation for Cognitive Enhancement in Alzheimer’s Disease (the NICE-AD Study): A Randomized Clinical Trial.” Neurodegenerative Disease Management, vol. 11, no. 4, July 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3f2e157116c25b24d2c499ade9320bdc&authtype=sso&custid=ns315887.
APA
Jessica Zwerling, Russell K. Portenoy, Helena Knotkova, Joe Verghese, Emma Gulley, Helena M. Blumen, Erica F. Weiss, Cuiling Wang, & Emmeline Ayers. (2021). Neurostimulation for cognitive enhancement in Alzheimer’s disease (the NICE-AD study): a randomized clinical trial. Neurodegenerative Disease Management, 11(4).
Chicago
Jessica Zwerling, Russell K. Portenoy, Helena Knotkova, Joe Verghese, Emma Gulley, Helena M. Blumen, Erica F. Weiss, Cuiling Wang, and Emmeline Ayers. 2021. “Neurostimulation for Cognitive Enhancement in Alzheimer’s Disease (the NICE-AD Study): A Randomized Clinical Trial.” Neurodegenerative Disease Management 11 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3f2e157116c25b24d2c499ade9320bdc&authtype=sso&custid=ns315887.